Found: 12
Select item for more details and to access through your institution.
Absolute Bioavailability of Vemurafenib in Patients With BRAF<sup>V600</sup> Mutation–Positive Malignancies.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 496, doi. 10.1002/cpdd.773
- By:
- Publication type:
- Article
Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 3, p. 595, doi. 10.1111/bjh.15571
- By:
- Publication type:
- Article
Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2012, v. 74, n. 5, p. 788, doi. 10.1111/j.1365-2125.2012.04281.x
- By:
- Publication type:
- Article
Body weight-supported treadmill training vs. overground walking training for persons with chronic stroke: a pilot randomized controlled trial.
- Published in:
- Clinical Rehabilitation, 2014, v. 28, n. 9, p. 873, doi. 10.1177/0269215514520773
- By:
- Publication type:
- Article
Body weight-supported treadmill training vs. overground walking training for persons with chronic stroke: a pilot randomized controlled trial.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER‐Medicare analysis.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 17, p. 6216, doi. 10.1002/cam4.3256
- By:
- Publication type:
- Article
Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A clinical drug-drug interaction study to evaluate the effect of a proton-pump inhibitor, a combined P-glycoprotein/cytochrome 450 enzyme (CYP)3A4 inhibitor, and a CYP2C9 inhibitor on the pharmacokinetics of vismodegib.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 193, doi. 10.1007/s00280-012-1996-6
- By:
- Publication type:
- Article
Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Digoxin in Patients With BRAF<sup>V600</sup> Mutation–Positive Metastatic Malignancy.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 8, p. 1067, doi. 10.1002/jcph.1111
- By:
- Publication type:
- Article